P
roteasomes mediate the majority of cellular protein turnover, promoting multiple signaling pathways, cell cycle progression, and general cellular homeostasis (1) . These large, multisubunit complexes also permit immune detection of virally infected cells by generating the foreign peptides displayed by major histocompatibility complexes (MHCs) (2) . In addition to this prominent antiviral role, proteasomes promote viral infection through the degradation of cellular factors that restrict viral infection. The dichotomous roles of proteasomes during viral infection and their general requirement for cellular health necessitate that viruses modulate proteasomal activities in a precise manner to promote viral infection (3) (4) (5) .
The barrel-like 20S catalytic core particle (CP) of the proteasome, consisting of two sets of seven distinct alpha (␣1 to ␣7) and beta (␤1 to ␤7) subunits, contains the proteolytic components responsible for protein degradation (including the ␤1 caspase-, ␤2 trypsin-, and ␤5 chymotrypsin-like subunits) (6) . One or both ends of the 20S CP can associate with an assortment of proteasome activators that vary proteasome CP accessibility and function (7) . For example, the 20S CP associates with the 19S regulatory particle (RP) to form the 26S proteasome. The 19S RP is a proteasome activator made up of at least 18 distinct subunits that are classified as either base or lid components (8) . The base of the 19S RP directly contacts the 20S CP and contains six ATPase subunits (Rpt1 to Rpt6), as well as two non-ATPase subunits (Rpn1 and Rpn2). The lid consists of eight subunits (Rpn3, -5, -6, -7, -8, -9, -11, and -12), one of which (Rpn11) contains deubiquitinase activity (9) . Rpn10 and Rpn13 are ubiquitin receptors that show association with the 19S RP (10, 11) . The 26S proteasome complex mediates the majority of ubiquitin-dependent protein degradation within cells but catalyzes ubiquitin-independent degradation as well (12, 13) .
At the start of lytic infection, human cytomegalovirus (HCMV), a ubiquitous herpesvirus that causes significant morbidity and mortality in individuals with compromised immune systems, subverts 26S proteasome function for the degradation of key cellular factors capable of restricting viral replication (14) (15) (16) (17) (18) (19) (20) . Upon entry, HCMV virions deposit the viral tegument protein pp71 into the cell, where it commandeers the 26S proteasome to degrade cellular transcriptional corepressors Daxx, BclAF-1, retinoblastoma protein (Rb), p107, and p130 to promote viral gene expression (16, 18, 19, (21) (22) . Interestingly, in the only two cases analyzed (Daxx and Rb), these degradation events do not require prior substrate ubiquitination but still utilize the 19S RP, a proteasome activator predominantly associated with ubiquitin-dependent processes (13, 19, 23) .
In addition to their roles in ubiquitin-dependent (1) and ubiquitin-independent (24) proteasomal degradation events, 19S RP subunits are emerging as transcriptional regulators independent of their association with the 20S CP. In vitro transcription with human RNA polymerase II (RNAPII) requires the 19S RP, while 19S RP subunits promote transcriptional elongation and are found associated with active promoters in Saccharomyces cerevisiae (25) (26) (27) (28) . Furthermore, Tat-mediated transcription from an integrated HIV-1 long terminal repeat requires 19S RP function (29) . During the late stages of HCMV infection, 19S RP subunits relocalize to the periphery of replication compartments where there are robust levels of transcription (30) , but the significance of this phenomenon is not understood. While small-molecule inhibitor studies have demonstrated a role for the 20S CP in HCMV gene expression (18, 30, 31) , here we explore a role for 19S subunits in that process. We found that 19S RP subunits are recruited to and required for efficient transcriptional initiation and elongation of the major immediate early (MIE) locus at the early stages of HCMV infection. In contrast, the 20S CP is neither recruited to the pro- moter nor required for transcriptional elongation but does promote RNA polymerase II (RNAPII) occupancy of the MIE promoter (MIEP), as expected. We thus define a nonproteolytic role for proteasome components in promoting HCMV immediate early (IE) gene expression.
MATERIALS AND METHODS

Cells and viruses.
Human foreskin fibroblasts (HFs), telomerase-immortalized human foreskin fibroblasts (tHFs), and cells depleted of Daxx by short hairpin RNA targeting Daxx (shDaxx) (32) were cultured as previously described (18) . Cells were infected with HCMV-AD169 as previously described (18) . For small interfering RNA (siRNA) experiments, the cell count of a companion scrambled (Scr) well was used to determine viral inocula for the desired multiplicity of infection (MOI) for all other wells. Cell cycle analysis by flow cytometry has been previously described (33) .
Inhibitors and antibodies.
Trichostatin A (TSA); 100 ng/ml in dimethyl sulfoxide ([DMSO]) (Millipore) was added 20 h prior to infection; lactacystin (20 M in DMSO; Calbiochem) was added at the start of infection. Antibodies used for immunoblotting and chromatin immunoprecipitation (ChIP) assays are listed in Table 1 . Goat anti-mouse and goat anti-rabbit secondary antibodies conjugated with horseradish peroxidase were purchased from Chemicon and used for visualizing immunoblots with film as previously described (18) . Immunoblots for semiquantitative analysis were also analyzed using a Li-Cor Odyssey Fc imaging system as previously described (13) . All quantitative immunoblotting graphs represent the means Ϯ standard errors (SE) of at least three biological replicates and have been analyzed with two-tailed paired t tests.
RNA interference. Cells were transfected with small interfering RNA oligonucleotides from Dharmacon (Table 1) EDTA, 1% SDS, protease inhibitors) and subjected to sonication. Cellular debris was removed by centrifugation, and supernatants were diluted with ChIP dilution buffer (16.7 mM Tris [pH 8.1], 167 mM NaCl, 1.2 mM EDTA, 1.1% Triton X-100, 0.01% SDS, protease inhibitors) for overnight incubation with ChIP antibodies at 4°C. Magnetic protein A/G beads (Millipore) were added for 1 h, and beads were washed once with a lowsalt buffer (20 mM Tris [pH 8.1], 150 mM NaCl, 2 mM EDTA, 1% Triton X-100, 0.1% SDS), a high-salt buffer (20 mM Tris [pH 8.1], 0.5 M NaCl, 2 mM EDTA, 1% Triton X-100, 0.1% SDS), and a LiCl buffer (10 mM Tris [pH 8.1], 0.25 M LiCl, 1 mM EDTA, 1% NP-40, 1% DOC); they were washed twice with TE buffer (10 mM Tris [pH 8.0], 1 mM EDTA). Beads were then resuspended in water and incubated at 95°C for 10 min. The reaction mixtures were then reverse cross-linked for at least 30 min with ϳ80 mM NaCl and 10 g of proteinase K at 55°C. Reverse cross-linking was terminated at 95°C for 10 min, and DNA was isolated using a QIAquick PCR purification kit (28104; Qiagen) according to the manufacturer's protocol. Isolated DNA was analyzed by real-time PCR.
Real-time PCR. DNA and RNA were isolated using DNA and RNA extraction kits (IB47201 and IB47322; IBI Scientific) according to the manufacturer's protocol. To make cDNA, isolated nucleic acids were quantified, and equal amounts of extracted RNA were treated with DNase (M6101; Promega) and converted into first-strand cDNA using a SuperScript III first-strand synthesis system (18080-051; Invitrogen). Primer and probe sets for real-time analysis are listed in Table 2 . All real-time graphs represent the means Ϯ SE of at least three independent experiments and have been analyzed for statistical significance using a permutation test (Mstat, version 6.1.2) that utilizes each independent experiment analyzed in triplicate by quantitative PCR (qPCR).
RESULTS
19S RP subunit knockdown inhibits both Daxx degradation and IE1 transcript accumulation.
Depletion of the Daxx protein during HCMV infection, either naturally through degradation by tegument-delivered pp71 or artificially through RNA interference, stimulates viral IE gene expression (18, 34, 35) . Correspondingly, stabilization of Daxx through genetic alteration of pp71 or proteasome inhibition inhibits viral IE gene expression (18) . Because the 19S RP is required for Daxx degradation (13), we asked if it was also required for viral IE gene expression. Independent knockdown of three distinct 19S RP subunits (Rpn1, Rpt2, and Rpn11) stabilized Daxx and impaired IE1 protein accumulation during HCMV infection (Fig. 1A to D) . 19S RP subunit knockdown was confirmed by Western blotting, and inhibition of 19S RP function was confirmed by observing the stabilization of p53, a constitutively degraded 26S proteasome substrate (36) . Consistent with the known role for Daxx in suppressing IE1 transcription (18, 32, 37) , 19S RP knockdown suppressed the accumulation of IE1 transcripts ( Fig. 2A and B) . We found no defects in HCMV genome delivery ( Fig. 2C and D) or cell cycle synchronization by serum starvation (Fig. 2E ) in 19S RP subunit knockdown cells that could explain the observed inhibition of IE gene expression. Thus, we conclude that 19S RP subunit depletion inhibits HCMV IE1 transcription.
Maintenance of the intrinsic defense through 19S RP knockdown is not the sole reason for depressed IE1 transcription.
Daxx institutes an intrinsic defense against HCMV that silences viral IE gene expression. It is inactivated through Daxx degradation by tegument-delivered pp71 or pharmacological histone deacetylase (HDAC) inhibition (18) and is maintained by proteasome impairment through small-molecule inhibition of the 20S CP or 19S RP subunit knockdown (13, 18) . The silencing of IE gene expression observed upon 20S CP inhibition can be reversed by Daxx knockdown or HDAC inhibition (18) , indicating that the intrinsic defense is the sole or major impediment to IE gene expression in 20S CP-inhibited cells. In contrast, Daxx knockdown (Fig. 3A) or HDAC inhibition (Fig. 3B) failed to rescue IE1 protein accumulation in 19S RP knockdown cells. While HDAC inhibition could rescue IE1 transcription during 20S CP knockdown, it was unable to promote IE1 transcription during 19S RP knock- down (Fig. 3C) . We conclude that in addition to maintaining the Daxx-and HDAC-mediated intrinsic defense by disabling pp71-mediated Daxx degradation, 19S RP knockdown triggers an additional restriction to HCMV IE1 transcription.
The 19S RP is recruited to the MIE locus at the onset of HCMV infection and promotes transcriptional elongation. Inhibition of both the 20S CP and the 19S RP impairs protein degradation and HCMV IE gene expression. The observations that Daxx knockdown or HDAC inhibition can rescue IE gene expression only upon 20S CP but not 19S RP inhibition implies a nonproteolytic role for the 19S RP in HCMV transcription. Indeed, a nonproteolytic role for the 19S RP in cellular gene expression is emerging (38) . While mechanisms remain elusive, 19S RP subunits have been observed at transcriptionally active loci (25, 29) , and their presence promotes transcriptional elongation (26, 29) . Likewise, using immunoprecipitation (ChIP), we found the endogenous 19S RP subunit Rpn7 but not the 20S CP subunit ␤7 present at the MIE locus, both at the promoter (Fig. 4A ) and within exon 3 (Fig. 4B) , in HCMV-infected cells. At this time during infection, the UL47 and UL48 genes are not transcribed. Encoded by the same DNA strand, these genes at late times after infection generate transcripts with unique 5= ends but identical 3= termini (39) . Rpn7 showed a very modest recruitment to the 5= (promoter) region of the UL47 gene (Fig. 4C ) that may represent poising for future transcription, as has been postulated for cellular genes (40). Rpn7 was not recruited to the 3= end of the UL48 gene (Fig. 4D) . Thus, the 19S RP is recruited more substantially to the actively transcribed MIE locus than the transcriptionally inactive UL47/48 locus. The ability of the ␤7 antibody to immunoprecipitate the endogenous protein (Fig. 4E) instills confidence in the accuracy of the negative ChIP experiments.
We also utilized ChIP experiments to gauge transcriptional elongation by quantifying RNAPII occupancy at three sites within the MIE locus ( Fig. 5A and 6A ): the promoter, exon 4, and exon 5. Furthermore, we used an antibody that recognizes the nonphosphorylated form of RNAPII (8WG16) or one (H5) that recognizes RNAPII only when it is phosphorylated on serine 2, a mark of a transcriptionally elongating polymerase (41) . Knockdown of the 19S RP subunit Rpn1 decreased the occupancy of total RNAPII at the MIEP, exon 4, and exon 5 ( Fig. 5B ) and of serine 2-phosphorylated RNAPII at exon 5 (Fig. 5C ). In contrast, knockdown of the 20S CP subunit ␤5 impaired RNAPII recruitment to the MIEP but not occupancy at exon 4 or exon 5 ( Fig. 6B ) and had no effect on exon 5 occupancy of serine 2-phosphorylated RNAPII (Fig. 6C) . Western blot controls indicated that proteasome subunit knockdown was achieved and impaired proteasome activity (detected by stabilization of p53) but that it did not affect the steady-state levels of the relevant forms of RNAPII (Fig. 7) . From these data we conclude that the 19S RP, but not the 20S CP, facilitates RNAPII transcriptional elongation through the MIE locus in HCMV-infected cells. In total, our work uncovers proteolytic and nonproteolytic roles for the 19S RP in promoting viral IE gene expression at the onset of HCMV lytic infection.
DISCUSSION
The ubiquitin-proteasome pathway affects multiple cellular pathways during infections with many different viruses, with the proteolytic functions of the proteasome being the most appreciated and well studied. For example, adenovirus, human papillomavirus (HPV), and HCMV degrade substrates involved in cell cycle progression (42); HCMV, herpes simplex virus 1 (HSV-1), and HIV-1 destroy cellular restriction factors that inhibit viral replication (43) (44) (45) ; and HCMV stimulates MHC class I downregulation to impair adaptive immunity (46, 47) . An additional growing body of evidence illustrates nonproteolytic ways in which the ubiquitin-proteasome system may be commandeered for the benefit of viral infections.
We previously reported that the monoubiquitination of histone H2B, which does not result in protein degradation, was required for efficient transcriptional elongation of HCMV genes (39) . Here, we show that HCMV also utilizes the 19S RP in a nonproteolytic manner to promote efficient viral gene expression, a finding mirrored for HIV (29) . Our overall data support a model whereby Daxx degradation by tegument-delivered pp71 and the 26S proteasome prevents repressive epigenetic modification of the MIEP, permitting RNAPII recruitment to the promoter and fostering transcriptional initiation. Subsequently, the 19S RP promotes efficient transcriptional elongation of RNAPII (Fig. 8) . Our results illuminate a novel role that the 19S RP plays during HCMV infection and provide a mechanistic rationale for previously published results demonstrating that 19S RP subunits localized to areas of robust transcription at late times postinfection (30) .
The inhibition of 19S RP function to impair HCMV IE gene transcriptional elongation may be a strategy for antiviral therapeutic intervention. It has recently been documented that decelerating the rate of HCMV gene expression confers a significant fitness cost to the virus (48) . Dampened yet detectable IE gene expression might slow viral replication while still producing viral antigens detectable by adaptive immune responses. In this respect, slowing IE gene expression through selectively impairing 19S RP function during transcriptional elongation may be more attractive than silencing IE gene expression through 20S CP inhibition as this leads to latent virus that cannot be cleared by the host immune system (34) .
How the 19S RP facilitates RNAPII elongation remains an enigma (49) . Potential mechanisms include stabilizing protein interactions within the elongation complex, recruiting positively acting elongating factors, or removing factors that slow transcrip-tional elongation. Our demonstration that the 19S RP promotes transcriptional elongation of viral genes establishes a physiologically relevant, genetically tractable model for further investigations to decipher the mechanism of nonproteolytic yet proteasome-mediated transcriptional regulation.
